Welcome to our dedicated page for Sabra Health Care Reit SEC filings (Ticker: SBRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Sabra Health Care REIT, Inc. (SBRA) SEC filings page on Stock Titan brings together the company’s regulatory disclosures as a Maryland-incorporated, self-administered, self-managed healthcare REIT listed on The Nasdaq Stock Market LLC. Through these filings, investors can review how Sabra reports its financial results, portfolio activity, capital structure decisions and other material events related to its healthcare real estate business in the United States and Canada.
Sabra’s Form 8-K filings frequently cover quarterly earnings releases, where the company presents net income alongside non-GAAP measures such as funds from operations (FFO), Normalized FFO, Adjusted FFO (AFFO), Normalized AFFO, net operating income (NOI), Cash NOI and Net Debt to Adjusted EBITDA. These filings often reference supplemental information packages and reconciliations of non-GAAP financial measures that explain how the metrics relate to GAAP results and how they reflect performance across skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities and specialty hospitals and other properties.
Other 8-K filings document capital markets transactions and financing activities, including equity distribution agreements supporting at-the-market equity offering programs, forward sale agreements for common stock, new term loans and the redemption of outstanding senior notes. These disclosures outline how Sabra raises capital, refinances debt and funds investments in its healthcare real estate portfolio.
On this page, Stock Titan provides real-time access to Sabra’s filings as they appear on EDGAR, along with AI-powered summaries that help explain key points from lengthy documents such as earnings-related 8-Ks and accompanying exhibits. Users can quickly locate quarterly and annual reports, review material definitive agreements, track changes in capital structure and understand the regulatory context around Sabra’s operations as a healthcare-focused REIT.
Sabra Health Care REIT, Inc. reported an equity award and related tax withholding for its Executive VP, CFO & Treasurer, Michael Lourenco Costa. On January 8, 2026, he acquired 85,690 shares of common stock at $0, reflecting the vesting of total stockholder return-based stock units granted under the company’s 2009 Performance Incentive Plan, including 18,014 shares from dividend equivalents. The compensation committee determined that 200% of the target TSR units were earned over a three-year performance period, and the vested units will be settled one-for-one in common shares on or about January 2, 2027, subject to earlier payment in specified events.
On the same date, 46,132 shares were withheld at $19.61 per share to satisfy tax obligations tied to previously vested restricted stock units. Following these transactions, Costa directly beneficially owned 434,668 common shares, plus indirect holdings of 784 shares in his IRA and 207 shares in his spouse’s IRA. His holdings also include 251,562 stock units payable in an equal number of common shares upon settlement.
Sabra Health Care REIT, Inc. reported insider equity activity for Chair, CEO and President Richard K. Matros. On January 8, 2026, 319,394 shares of common stock vested from relative total stockholder return-based stock units granted on December 27, 2022, including 67,146 shares tied to dividend equivalents. The Compensation Committee determined that TSR units were earned at 200% of target, and the vested units will be settled one-for-one in common shares on or about January 2, 2027, subject to earlier payout upon death, disability or change of control.
The filing also shows 223,944 shares withheld at $19.61 per share to cover tax obligations related to previously vested restricted stock units. In addition, 232,936 shares acquired from previously vested restricted stock units were transferred from Matros directly to the R&A Matros Revocable Trust, which held 1,857,686 shares of common stock after the reported transactions.
Sabra Health Care REIT, Inc. executive Darrin Smith, Executive VP, CIO & Secretary, filed an initial Form 3 reporting his beneficial ownership in the company. He reports holding 101,876 shares of common stock, including 44,034 stock units that will each convert into one share of common stock upon settlement. All reported holdings are listed as directly owned, with no derivative securities reported.
Sabra Health Care REIT, Inc. (SBRA) reported Q3 results and executed notable portfolio and financing moves. Total revenues were $190,037, driven by resident fees and services of $92,017 and rental and related revenues of $85,354. Net income was $22,517 (diluted EPS $0.09). For the nine months, revenues were $562,730 with net income of $128,384.
Year-to-date, Sabra acquired seven Senior Housing - Managed communities (total consideration $283,090) and purchased the operations of four previously leased communities for $19.7 million, while selling eight facilities for $42.9 million and recognizing a $5.5 million net gain. The company redeemed its $500,000 5.125% notes due 2026 and entered a new $500,000 term loan maturing in 2030, supported by interest rate swaps. As of September 30, 2025, cash was $200,602, the revolving credit facility balance was $282,213 with $717.8 million available, and shares outstanding were 249,349,673 as of October 29, 2025.
Sabra Health Care REIT (SBRA) furnished materials reporting results for the three months ended September 30, 2025. The company provided a press release (Ex. 99.1), a supplemental information package (Ex. 99.2), non-GAAP reconciliations (Ex. 99.3), and an investor presentation (Ex. 99.4). These Items 2.02 and 7.01 materials are furnished, not filed, and the reconciliations and supplemental data are also available on Sabra’s investor website.
Jeffrey A. Malehorn, a director of Sabra Health Care REIT, Inc. (SBRA), was credited with 813 common stock units as dividend equivalents on 08/29/2025. These units were granted under the issuer's 2009 Performance Incentive Plan and carry a $0 per-unit acquisition price because they reflect dividend equivalent payments on previously granted stock units. After the transaction the reporting person beneficially owned 105,630 shares or share-equivalents in total, including 6,922 unvested stock units and 45,688 vested units for which payment has been deferred. Each stock unit corresponds to the right to one share and the credited units will vest and pay out on the same schedule as the original awards.
Kono Ann, a director of Sabra Health Care REIT, Inc. (SBRA), received 887 stock units on 08/29/2025 as dividend equivalent payments tied to previously granted performance-based stock units under the 2009 Performance Incentive Plan. These units were credited at no cash cost to the reporting person and will vest and be payable on the same terms as the original awards. After the transaction the reporting person beneficially owned 57,396 stock units, comprising 6,922 unvested units and 50,474 vested units for which payment has been deferred.
Reporting person: Lynne S. Katzmann, a director of Sabra Health Care REIT, Inc. (SBRA). Transaction date: 08/29/2025; Form filed: Form 4 signed 09/03/2025 by attorney-in-fact.
The report shows 813 stock units were acquired as dividend equivalent payments on previously granted stock units under the Issuer's 2009 Performance Incentive Plan at a reported price of $0. After the transaction the reporting person beneficially owns 75,405 shares equivalent, which include 6,922 unvested stock units and 45,688 vested stock units with deferred payment. Each stock unit represents the right to receive one share of the Issuer's common stock. The acquired dividend-equivalent units will vest and be payable on the same terms as the original awards.
Sabra Health Care REIT director Michael J. Foster was credited with 813 stock units on 08/29/2025 as dividend-equivalent payments tied to previously granted performance stock units; those units carry the same vesting and payment terms as the original awards. After the reported transaction, Foster beneficially owns 73,130 shares (including 6,922 unvested units and 45,688 vested units with deferred payment). In addition, Foster holds 42,411.745 shares indirectly through a 401(k) plan.
The Form 4 reflects routine insider equity compensation mechanics rather than an open-market purchase or sale: the 813 units were credited at $0 as dividend equivalents and will vest/pay under the existing plan terms.
Catherine Cusack, a director of Sabra Health Care REIT, Inc. (SBRA), was credited with 877 additional common stock units on 08/29/2025 as dividend equivalent payments under the Issuer's 2009 Performance Incentive Plan at no cash cost. Following the transaction she beneficially owns 71,276 shares or stock units in total, which includes 6,922 unvested stock units and 49,854 vested units with deferred payment. Each stock unit equals the right to receive one share of common stock and the dividend-equivalent units will vest and pay out on the same schedule as the original awards.